Bal Pharma P/B Ratio
Bal Pharma (BALPHARMA) P/B ratio is 1.61 (Moderate), book value per share ₹48.12 vs Healthcare average P/B of -0.94 — Moderate - Reasonably valued relative to book value. Compare with BALPHARMA fair value to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
BALPHARMA P/B Ratio — Valuation Insights & Book Value Analysis
Bal Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 1.61 (Moderate). For live price, earnings yield and the full fundamental profile, see BALPHARMA stock price BSE.
- Current PB is 33.3% below historical average
- Trading at premium to sector average PB of -0.94
Bal Pharma P/B Ratio Historical Trend
BALPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View BALPHARMA 52-week chart for the annual high/low range and current price position.
BALPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price
Bal Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.52 | ₹48.12 | ₹73.32 | ₹77 | Moderate |
| 2024 | 2.72 | ₹45.0 | ₹122.62 | ₹72 | Moderate |
| 2023 | 2.5 | ₹40.0 | ₹100.05 | ₹64 | Moderate |
| 2022 | 2.32 | ₹39.33 | ₹91.15 | ₹59 | Moderate |
| 2021 | 3.0 | ₹35.33 | ₹105.85 | ₹53 | Moderate |
BALPHARMA vs Healthcare Peers — P/B Ratio Comparison
Bal Pharma P/B 1.61 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |